IMU (ASX) IMUGENE CHART. TA only

Originally posted by fourdollars: ↑

Oh dear, King Zior has put me in the naughty corner. How will I cope?

Why would I change what I'm criticising when the very thing I'm criticising only gets worse?

It is surprising that a charting specialist - a completely objective discipline - is so subjective (delusional?) when it comes to assessing IMU's fundamentals. Fundamentals which have objectively trumped your technical analysis for more than two years.

The cheersquad will keep deluding themselves that the "fundamentals have only gotten stronger" and "IMU has only ever made positive announcements" even in the face of the jewel in IMU's crown for the past decade now being "de-prioritised". They will also delude themselves that all SP weakness is because of manipulators and shorters (who apparently have been bashing away on a daily basis for over two years). They will delude themselves that Hopper is better for a biotech than Hoos.

If you did go back to my posts, you will see that I was complimentary about the CF33 progress and particularly about IMU's first ever external endorsement of something it is doing (the FDA fast-track). But in spite of these two indisputably positive developments, we are seeing SP weakness. The SP weakness is occurring - as predicted - after the Board was left intact and the greedy self-awarded rewards hit a new, sickening high. And this was done at the very next opportunity after the remuneration strike. No strike this year .... imagine what level the remuneration will get to next year now that Hopper has been "endorsed".

With all this objective evidence, you still think that the Hopper / Leslie show is not the biggest drag on IMU value? CF33 and Professor Fong are probably going better and faster than anyone anticipated, yet not one unpaid fund manager or investment analyst covers the stock - even though it was in the ASX200 for two years.

Make all the personal attacks you like, but its not going to change the fact that with the current management team IMU is simply not considered investment-grade by the serious investment community.

Its not a matter of pessimism. I'm optimistic and hopeful that CF33 will be the cancer-buster that it potentially could be. I'm sure that if it is, IMU will sell for multiples of its current SP. But I'm realistic enough to acknowledge that if / when IMU sells, it will be for a fraction of what it could have with a more respectable management team.

As shareholders, we can't add value by advancing the science. However, we can add value by acknowledging the shortcomings of the management team and making an effort to change it. We failed to do so while Hopper engineered the removal of Axel Hoos. It was easy, the SP was going up. To waste an opportunity in the face of a decimated SP, and more and more evidence that poor management it diminishing the benefits of scientific advancement, is frustrating to say the least.

Expand

if we have patented treatments which deliver “complete responses” to severe cancer it won’t matter ok. We are not selling soda here. In that case with the complete board of directors- they will consider all offers from the BP market….so we have to trust the process . If you do not trust the BOD, well I guess you have to move onto a new rodeo…

No.	Vol.	Price($)
31	1854997	5.2¢

No.

Vol.

Price($)

1854997

5.2¢

Price($)	Vol.	No.
5.3¢	382882	4

Price($)

Vol.

No.

5.3¢

382882

No.	Vol.	Price($)
31	1854997	0.052
39	5099678	0.051
52	4172179	0.050
17	2263068	0.049
20	996329	0.048

No.

Vol.

Price($)

1854997

0.052

5099678

0.051

4172179

0.050

2263068

0.049

996329

0.048

Price($)	Vol.	No.
0.053	382882	4
0.054	3593651	7
0.055	1701991	16
0.056	2970606	12
0.057	803139	8

Price($)

Vol.

No.

0.053

382882

0.054

3593651

0.055

1701991

0.056

2970606

0.057

803139

(20min delay)
Last 5.2¢		Change -0.001(1.89%)		Mkt cap ! $382.1M

Open	High	Low	Value	Volume
5.3¢	5.4¢	5.2¢	$216.1K	4.106M

if we have patented treatments which deliver “complete...

Appliances and furnishings impress - will Harvey Norman be next?

MOVE Logistics picks new interim CEO to take over operations from early September

Bitcoin: Current State of Play & Where to Next | Swyftx

Auric banks $6.3M in August with processing on-target for 300K in 2024

EIS co-funded campaign sees Miramar kick off maiden drilling at Bangemall, Gascoyne WA

Golden Mile ditches Marble Bar and Murchison tenements after weak fieldwork results

Emerald & Azure score Digger & Dealer awards

Wellnex sees first special access scheme prescriptions for new Wellness Life brand

Victory Metals dips -8% even as company set to grow heavy REE resource at North Stanmore

Argent begins search for VMS mineralisation at Kempfield Cu-Pb-Zn-Au-Ag play in NSW

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

if we have patented treatments which deliver “complete...

Top Stories

Appliances and furnishings impress - will Harvey Norman be next?

MOVE Logistics picks new interim CEO to take over operations from early September

Bitcoin: Current State of Play & Where to Next | Swyftx

Auric banks $6.3M in August with processing on-target for 300K in 2024

EIS co-funded campaign sees Miramar kick off maiden drilling at Bangemall, Gascoyne WA

Golden Mile ditches Marble Bar and Murchison tenements after weak fieldwork results

Emerald & Azure score Digger & Dealer awards

Wellnex sees first special access scheme prescriptions for new Wellness Life brand

Victory Metals dips -8% even as company set to grow heavy REE resource at North Stanmore

Argent begins search for VMS mineralisation at Kempfield Cu-Pb-Zn-Au-Ag play in NSW

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News